Define Optimal 2nd Line Treatment and Sequence: Biomarker

Define Optimal 2nd Line Treatment and Sequence: Biomarker

kidneycancer

3 years
657 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Gabriel Malouf, MD, PhD of Pitié-Salpêtrière Hospital Defines Optimal 2nd Line Treatment and Sequence: Biomarker at the 12th European International Kidney Cancer Symposium 2017
Up Next Autoplay